Какова цена за Alimera Sciences, Inc. (ALIM)

Цена за Alimera Sciences, Inc. (ALIM) Это $5.54

Какова рыночная капитализация для Alimera Sciences, Inc. (ALIM)

Рыночная капитализация для Alimera Sciences, Inc. (ALIM) Это $38.76M

Alimera Sciences, Inc. (ALIM) Дробление Акций

Alimera Sciences, Inc. is a pharmaceutical company focused on developing and commercializing ophthalmic treatments globally, including in the United States. Its primary offering, ILUVIEN, is an intravitreal implant used to manage diabetic macular edema (DME), a severe retinal disease in individuals with diabetes that can lead to profound vision loss and blindness. Additionally, ILUVIEN helps prevent relapses of recurrent non-infectious uveitis affecting the posterior segment of the eye. The company distributes its products directly and through distributors to various healthcare entities such as physician offices, pharmacies, and hospitals. Alimera also maintains a collaboration with EyePoint Pharmaceuticals US, Inc. focused on developing and marketing insert technology. This technology is designed to deliver corticosteroids to the back of the eye for treating and preventing various human eye diseases, including diabetic macular edema. Founded in 2003, Alimera Sciences is headquartered in Alpharetta, Georgia.

Год	Дробление	Коэффициент	Суммарный коэффициент
2019-11-15	1:15	x0.066666666666667	x0.066666666666667

Год

Дробление

Коэффициент

Суммарный коэффициент

2019-11-15

1:15

x0.066666666666667

Компания	Количество дроблений акций	Суммарный коэффициент	Страна
MERCK Kommanditgesellschaft auf Aktien MER.SW	0	-	DE
Merck KGaA MRK.DE	0	-	DE
Takeda Pharmaceutical Company Limited 4502.T	0	-	JP
Galderma Group AG GALD.SW	0	-	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	5	x119	IN

Компания

Количество дроблений акций

Суммарный коэффициент

Страна